ATE445404T1 - Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose - Google Patents

Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose

Info

Publication number
ATE445404T1
ATE445404T1 AT05706024T AT05706024T ATE445404T1 AT E445404 T1 ATE445404 T1 AT E445404T1 AT 05706024 T AT05706024 T AT 05706024T AT 05706024 T AT05706024 T AT 05706024T AT E445404 T1 ATE445404 T1 AT E445404T1
Authority
AT
Austria
Prior art keywords
adefovir
tenofovir
mmtv
breast cancer
inhibit
Prior art date
Application number
AT05706024T
Other languages
English (en)
Inventor
Tomas Cihlar
Janet Douglas
Craig Gibbs
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of ATE445404T1 publication Critical patent/ATE445404T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT05706024T 2004-01-21 2005-01-21 Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose ATE445404T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (1)

Publication Number Publication Date
ATE445404T1 true ATE445404T1 (de) 2009-10-15

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05706024T ATE445404T1 (de) 2004-01-21 2005-01-21 Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose

Country Status (11)

Country Link
US (2) US20050239753A1 (de)
EP (1) EP1732569B1 (de)
JP (1) JP2007518815A (de)
AT (1) ATE445404T1 (de)
AU (1) AU2005209256B2 (de)
CA (1) CA2553455A1 (de)
DE (1) DE602005017131D1 (de)
ES (1) ES2334149T3 (de)
HK (1) HK1099228A1 (de)
NZ (1) NZ548532A (de)
WO (1) WO2005072748A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114065A2 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry A Cademy Of Sciences Of The Czech Republic Use of compounds to inhibit neoplasia
WO2007136650A2 (en) 2006-05-16 2007-11-29 Gilead Sciences, Inc. Method and compositions for treating hematological malignancies
ES2566762T3 (es) * 2009-10-05 2016-04-15 Ambergen Inc. Un procedimiento de diagnóstico de cirrosis biliar primaria (PBC) usando nuevos autoantígenos
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
CN104185420B (zh) 2011-11-30 2017-06-09 埃默里大学 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
KR20170123308A (ko) 2014-12-26 2017-11-07 에모리 유니버시티 Ｎ4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
BR122022008466B1 (pt) 2017-12-07 2023-12-05 Emory University Uso de um composto
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
JPWO2020171225A1 (ja) * 2019-02-22 2021-12-16 一素 村田 ｍＴＯＲ阻害剤
WO2021003421A1 (en) * 2019-07-02 2021-01-07 Virago Vax Inc. Mammary tumor virus suppression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468737B1 (en) * 1999-06-01 2002-10-22 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
PT1190055E (pt) * 1999-06-30 2008-09-03 Univ Tulane Retrovírus endógeno humano
KR100767432B1 (ko) * 2000-07-21 2007-10-17 길리애드 사이언시즈, 인코포레이티드 포스포네이트 뉴클레오티드 유사체의 전구 약물과 그것의 선택 및 제조 방법
NZ536328A (en) * 2002-05-13 2007-11-30 Metabasis Therapeutics Inc Novel phosphonic acid based prodrugs of PMEA and its analogues

Also Published As

Publication number Publication date
DE602005017131D1 (de) 2009-11-26
AU2005209256B2 (en) 2010-11-18
HK1099228A1 (en) 2007-08-10
NZ548532A (en) 2009-09-25
CA2553455A1 (en) 2005-08-11
JP2007518815A (ja) 2007-07-12
AU2005209256A1 (en) 2005-08-11
EP1732569B1 (de) 2009-10-14
ES2334149T3 (es) 2010-03-05
US20050239753A1 (en) 2005-10-27
WO2005072748A1 (en) 2005-08-11
EP1732569A1 (de) 2006-12-20
US20070281911A1 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE445404T1 (de) Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose
PH12020551244A1 (en) Pd-1/pd-l1 inhibitors
EA201000777A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
NO20073068L (no) Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
DK1866324T3 (da) Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer
GT200600046A (es) Terapia de combinacion
IS7997A (is) Granisetron lyfjaplástur
ATE541848T1 (de) Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv
PH12019500513A1 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
DK1753512T3 (da) Tetrahydropyridothiophener
CY1109440T1 (el) Φωσφοϊνδολες ως αναστολεις hiv
MX2022001004A (es) Inhibidores de enzimas.
BR112023000205A2 (pt) Misturas fungicidas
GT200600106A (es) Agentes endoparasiticidas
UA117563C2 (uk) Композиція для лікування або профілактики хвороби, асоційованої з інфекцією впл
ECSP077378A (es) Isoxazoles sustituidos como fungicidas
CL2008001819A1 (es) Compuestos derivados de fenoxi-fluorobenceno sustituido; composicion farmaceutica; y uso en el tratamiento de enfermedades virales tales como vih y sida.
RU2010139486A (ru) Способ коррекции гиперэстрадиолемии и нормогонадотропного гипогонадизма у мужчин
EA202092733A1 (ru) Ингибиторы pd-1/pd-l1
UA88325C2 (en) Phosphoindoles as hiv inhibitors
UY28563A1 (es) Complejos metálicos de paladio y platino con tiosemicarbazonas derivadas de 5-nitrofurano, procedimiento de preparación y utilización
UA89625C2 (ru) Фосфонаты, монофосфонамидаты, бисфосфонамидаты для лечения вирусных заболеваний

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties